Ranbaxy Laboratories Recalls Skin Infection Drug, Sotret in the U.S.

Published: Nov 20, 2009

Business-Standard.com -- India’s leading drug maker Ranbaxy has initiated a voluntary recall of 4,348 cartons of its skin infection drug Sotret (isotretinoin) in the United States. The entire lot pertains to a single batch of tablets which were found to be ‘out of specification’.

Back to news